Vir Biotechnology (VIR)

Trade VIR now with
8/31/2020 8:05:35 AM Vir Biotechnology, GSK Begin Phase 2/3 Study Of COVID-19 Antibody Treatment
7/7/2020 10:54:34 PM Vir Biotechnology Announces Pricing Of Underwritten Public Offering Of 7.14 Mln Shares At $42.00/shr
7/6/2020 7:12:25 AM Vir Biotechnology Plans Proposed Public Offering Of 6.20 Mln Shares
5/29/2020 8:13:54 AM Vir Biotechnology Finalizes Process Development And Manufacturing Agreement With Biogen
5/27/2020 8:22:23 AM Vir Biotechnology Initiates Phase 1 Clinical Trial Of VIR-3434 For Chronic Hepatitis B Virus Infection
5/4/2020 7:34:03 AM Vir Biotechnology And Alnylam Identify VIR-2703 Targeting SARS-CoV-2 For Treatment Of COVID-19
4/6/2020 8:16:40 AM GSK, Vir Biotechnology Collaborate To Find Coronavirus Solutions
3/30/2020 7:10:54 AM Generation Bio, Vir Biotechnology To Partner On Research To Leverage Scalable Non-Viral Gene Therapy Platform
3/25/2020 8:13:51 AM Vir Biotechnology Announces Multiple Antibodies Identified That Neutralize SARS-CoV-2